Welcoming Deborah Mash, Doctor, Scientist and Neuroshaman to the Awake Board

Dr. Deborah C. Mash is a Professor of Neurology (Emerita) and Molecular and Cellular Pharmacology at the University of Miami School of Medicine. With over 25 years of continuous NIH funding from the National Institute on Drug Abuse, Deborah is a leading expert on ibogaine and the discoverer of its active metabolite, noribogaine. She secured FDA approval for the first clinical trial of ibogaine in the U.S. in 1993 and conducted research and clinical development studies at a substance abuse treatment center in St. Kitts from 1996 to 2005. In 2010, Deborah co-founded DemeRx to advance noribogaine’s clinical development and took on leadership of the company in 2017. Dr Mash joined the Awake.net Board of Directors June 16th 2025.

“By specifically targeting structural neuroplasticity within the brain’s addiction circuitry, DMX-1001 aims to facilitate lasting changes that empower individuals to overcome the challenges of alcohol and drug addiction.”
Deborah Mash, PhD, CEO and Founder, Demerx.com

Dr Mash’s mission to help people overcome addiction is aligned with Awake.net’s FEAT mission to end addiction one ibogaine treatment at a time, and creates a very complementary alignment of interests and opportunities to bring together the scientific and the spiritual in the FEAT program and create a medically-supervised mystery school pathway for individuals wishing to end their addiction and rejoin society with purpose and passion.

Learn more about the FEAT Fund for Entheogenic Addiction Treatment, the FEAT Journey of Rebirth, and the FEAT Care Team.